Filed: 11/14/2025ACC: 0001104659-25-112500
📋 What this filing means
FORESITE CAPITAL MANAGEMENT IV, LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $182.61M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$182.61M
Total AUM (reported)
7.72M
Total Shares
Allocation by class
COM$182.61M100.0%
Portfolio Concentration
Top 3$157.97M86.5%
4–10$24.64M13.5%
Top 3 weight
86.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.72M
Sole
Full voting authority
7.72M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
Pharvaris N.V.
SOLEShares4.78M
TypeSH
Market value$119.23M
65.29%
Sole
4.78M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares458.30K
TypeSH
Market value$25.19M
13.79%
Sole
458.30K
Shared
0.00
None
0.00
Maze Therapeutics, Inc.
SOLEShares522.66K
TypeSH
Market value$13.55M
7.42%
Sole
522.66K
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
SOLEShares800.40K
TypeSH
Market value$13.00M
7.12%
Sole
800.40K
Shared
0.00
None
0.00
Xenon Pharmaceuticals Inc.
SOLEShares160K
TypeSH
Market value$6.42M
3.52%
Sole
160K
Shared
0.00
None
0.00
Relay Therapeutics, Inc.
SOLEShares1M
TypeSH
Market value$5.22M
2.86%
Sole
1M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Pharvaris N.V.SOLE | COM | 4.78M | SH | $119.23M 65.29% | 4.78M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM | 458.30K | SH | $25.19M 13.79% | 458.30K | 0.00 | 0.00 |
Maze Therapeutics, Inc.SOLE | COM | 522.66K | SH | $13.55M 7.42% | 522.66K | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 800.40K | SH | $13.00M 7.12% | 800.40K | 0.00 | 0.00 |
Xenon Pharmaceuticals Inc.SOLE | COM | 160K | SH | $6.42M 3.52% | 160K | 0.00 | 0.00 |
Relay Therapeutics, Inc.SOLE | COM | 1M | SH | $5.22M 2.86% | 1M | 0.00 | 0.00 |